CME: Radiojodbehandlung des Schilddrüsenkarzinoms
| Autor: | Susanne Aberle, Hans C. Steinert |
|---|---|
| Přispěvatelé: | University of Zurich, Steinert, Hans C |
| Jazyk: | němčina |
| Rok vydání: | 2015 |
| Předmět: |
Oncology
endocrine system medicine.medical_specialty endocrine system diseases business.industry medicine.medical_treatment chemistry.chemical_element 610 Medicine & health 10181 Clinic for Nuclear Medicine 2700 General Medicine General Medicine medicine.disease Iodine Iodine Radioisotopes Thyroid carcinoma Radiation therapy chemistry Internal medicine medicine Adenocarcinoma Thyroglobulin Radiology business Thyroid cancer Tumor marker |
| Popis: | Differentiated thyroid carcinomas represent about 90% of all thyroid tumors and are divided in papillary and follicular carcinomas. Their prognosis is good, however, recurrences are not rare. Their ability to accumulate iodine is used for the radioactive iodine treatment. The aim of the postoperative radioactive iodine ablation therapy is the complete elimination of remnant thyroid cells and sensitive staging (Fig. 1). The recurrence rate decreases after a complete thyroid ablation. Furthermore, thyroglobulin can be used as a sensitive tumor marker. Radioactive iodine treatment by itself describes the therapy of metastases. An exception is the papillary microcarcinoma, which in general is treated by a lobectomy alone. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|